Literature DB >> 15353292

Mechanisms of HTLV-1 transformation.

Kylene Kehn1, Reem Berro, Cynthia de la Fuente, Katharine Strouss, Elodie Ghedin, Shabnam Dadgar, Maria Elena Bottazzi, Anne Pumfery, Fatah Kashanchi.   

Abstract

HTLV-1 is the etiological agent of the fatal disease adult T-cell leukemia. The virus encodes many proteins including several accessory proteins, p12I, p13II, p27I, and p30II, whose roles have recently begun to be elucidated. These accessory proteins are important in T-cell activation, transcriptional regulation, viral persistence, and virus assembly. The viral oncogene Tax is thought to be largely responsible for tumorigenesis, although the precise mechanisms underlying transformation are not completely understood. Tax has a profound impact on transcription, cell growth regulation, genomic stability and apoptosis. This review will provide possible contributions of the accessory proteins to transformation as well as highlight the alterations of the above-mentioned cellular events by Tax. Animal models of both Tax and the accessory proteins are also included based on the essential information on the transformation process in vivo that they provide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353292     DOI: 10.2741/1401

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  12 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

3.  Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1.

Authors:  Seung-Jae Kim; Amrithraj M Nair; Soledad Fernandez; Lawrence Mathes; Michael D Lairmore
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

4.  Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.

Authors:  Li Xie; Patrick L Green
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein.

Authors:  Isabelle Lamsoul; Julie Lodewick; Sylvie Lebrun; Robert Brasseur; Arsène Burny; Richard B Gaynor; Françoise Bex
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

6.  PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo.

Authors:  Li Xie; Brenda Yamamoto; Abdelali Haoudi; O John Semmes; Patrick L Green
Journal:  Blood       Date:  2005-11-01       Impact factor: 22.113

Review 7.  Human T-cell leukemia virus type 1 Tax and cellular transformation.

Authors:  Jean-Marie Peloponese; Takao Kinjo; Kuan-Teh Jeang
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

8.  Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway.

Authors:  Julie Lodewick; Isabelle Lamsoul; Angela Polania; Sylvie Lebrun; Arsène Burny; Lee Ratner; Françoise Bex
Journal:  Virology       Date:  2009-02-05       Impact factor: 3.616

9.  Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB.

Authors:  Jean-Marie Peloponese; Junichiro Yasunaga; Takao Kinjo; Koichi Watashi; Kuan-Teh Jeang
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

10.  Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells.

Authors:  Kyung-Jin Jung; Arindam Dasgupta; Keven Huang; Soo-Jin Jeong; Cynthia Pise-Masison; Katerina V Gurova; John N Brady
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.